The latest episode of the In Vivo podcast features an interview with Phil L'Huillier, who discusses the inclusion of Scancell's melanoma cancer vaccine on the NHS Cancer Vaccine Launch Pad, and how 2025 could be a pivotal year for the cancer vaccine field as a whole.

Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Share Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines

Sign up to save your podcasts

Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines

Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines

More shows like Citeline Podcasts

The Documentary Podcast

Nature Podcast

Economist Podcasts

Marketplace

Marketplace All-in-One

Exchanges

Decoder with Nilay Patel

The Long Run with Luke Timmerman

The Readout Loud

FT News Briefing

The Intelligence from The Economist

The Rachman Review

BioCentury This Week

Biotech Hangout

Money Stuff: The Podcast